ZEB1: New advances in fibrosis and cancer

被引:0
|
作者
Lin Cheng
Ming-Yuan Zhou
Ying-Jian Gu
Lei Chen
Yun Wang
机构
[1] China Medical University,Department of Clinical Pharmacology, School of Pharmacy
来源
关键词
ZEB1; EMT; Cancer; Chemoresistance; Fibrosis; Protein structure;
D O I
暂无
中图分类号
学科分类号
摘要
Zinc finger E-box binding homeobox 1 (ZEB1) is an important transcription factor in epithelial mesenchymal transition (EMT) which participates in the numerous life processes, such as embryonic development, fibrosis and tumor progression. ZEB1 has multiple functions in human body and plays a crucial part in some life processes. ZEB1 is vital for the formation and development of the organs in the embryonic period. The abnormal expression of ZEB1 is a predictor for the poor prognosis or the poor survival in several cancers. ZEB1 contributes to the occurrence of fibrosis, cancer and even chemoresistance. Some research is indicated that fibrosis is finally developed into the cancers. Therefore, ZEB1 is probably taken as a biomarker in fibrosis or cancer. In this review, it is predicted of the structure of ZEB1 and the protein binding sites of ZEB1 with some protein, and it is discussed about the roles of ZEB1 in fibrosis and cancer progression to elaborate the potential applications of ZEB1 in clinic.
引用
收藏
页码:1643 / 1650
页数:7
相关论文
共 50 条
  • [31] ZEB1 drives epithelial-to-mesenchymal transition in lung cancer
    Larsen, Jill E.
    Nathan, Vaishnavi
    Osborne, Jihan K.
    Farrow, Rebecca K.
    Deb, Dhruba
    Sullivan, James P.
    Dospoy, Patrick D.
    Augustyn, Alexander
    Hight, Suzie K.
    Sato, Mitsuo
    Girard, Luc
    Behrens, Carmen
    Wistuba, Ignacio I.
    Gazdar, Adi F.
    Hayward, Nicholas K.
    Minna, John D.
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (09): : 3219 - 3235
  • [32] ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM
    Xiang Zhang
    Zhen Zhang
    Qing Zhang
    Quansheng Zhang
    Peiqing Sun
    Rong Xiang
    Guosheng Ren
    Shuang Yang
    Cell Death & Disease, 9
  • [33] The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer
    Chen, Anna
    Wong, Christina S. F.
    Liu, Mira C. P.
    House, Colin M.
    Sceneay, Jaclyn
    Bowtell, David D.
    Thompson, Erik W.
    Moeller, Andreas
    ONCOTARGET, 2015, 6 (02) : 862 - 873
  • [34] Association of ZEB1 and Vimentin with poor prognosis in metaplastic breast cancer
    Zawati, Imen
    Jlassi, Aida
    Adouni, Olfa
    Nouira, Meriem
    Manai, Maroua
    Rahal, Khaled
    Driss, Maha
    Manai, Mohamed
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2022, 59
  • [35] Dualistic role of ZEB1 and ZEB2 in tumor progression
    Parfenyev, Sergey E.
    Daks, Alexandra A.
    Shuvalov, Oleg Y.
    Fedorova, Olga A.
    Pestov, Nikolay B.
    Korneenko, Tatyana V.
    Barlev, Nickolai A.
    BIOLOGY DIRECT, 2025, 20 (01)
  • [36] Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer
    Su, Wenjing
    Xu, Miao
    Chen, Xueqin
    Chen, Ni
    Gong, Jing
    Nie, Ling
    Li, Ling
    Li, Xinglan
    Zhang, Mengni
    Zhou, Qiao
    MOLECULAR CANCER, 2017, 16
  • [37] ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA
    Luo, Na
    Zhang, Kejing
    Li, Xin
    Hu, Yu
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2020, 121 (10) : 4176 - 4187
  • [38] Knockdown of ZEB1 reverses cancer stem cell properties in prostate cancer cells
    Perez, Gisella
    Lopez-Moncada, Fernanda
    Indo, Sebastian
    Torres, Maria Jose
    Castellon, Enrique A.
    Contreras, Hector R.
    ONCOLOGY REPORTS, 2021, 45 (05)
  • [39] Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer
    Wenjing Su
    Miao Xu
    Xueqin Chen
    Ni Chen
    Jing Gong
    Ling Nie
    Ling Li
    Xinglan Li
    Mengni Zhang
    Qiao Zhou
    Molecular Cancer, 16
  • [40] ZEB1 Expression in Peritoneal Malignant Mesothelioma
    Baxter-Stoltzfus, Amelia
    Viswanathan, Kartik
    Kluger, Michael
    Hibshoosh, Hanina
    Borczuk, Alain
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1757 - 1758